BIVI — BioVie Cashflow Statement
0.000.00%
Last trade - 00:00- $14.09m
- -$3.46m
Annual cashflow statement for BioVie, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -130 | -26.1 | -50.3 | -32.1 | -17.5 |
| Amortisation | |||||
| Non-Cash Items | 120 | 4.11 | 10 | 3.98 | 2.62 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.019 | 2.76 | -0.233 | -0.037 | -4.33 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -10.5 | -19 | -40.3 | -27.9 | -19 |
| Other Investing Cash Flow Items | — | — | -14.3 | 14.5 | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | — | — | -14.3 | 14.5 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.9 | 33.1 | 55.4 | 17.8 | 12.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.47 | 14.1 | 0.819 | 4.38 | -6.3 |